GESTIÓN EN SALUD PÚBLICA: New FDA Draft Guidance Aims to Protect Children who Participate in Clinical Trials | FDA

miércoles, 28 de septiembre de 2022

New FDA Draft Guidance Aims to Protect Children who Participate in Clinical Trials | FDA

New FDA Draft Guidance Aims to Protect Children who Participate in Clinical Trials | FDA

No hay comentarios:

Publicar un comentario

Suscribirse a: Enviar comentarios (Atom)